Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Gap Down - Time to Sell?

Key Points

• Bayer Aktiengesellschaft's shares gapped down from $8.70 to $8.50 before the market opened on Thursday, with the last traded price being $8.51.
• Several research firms, including Zacks Research and Goldman Sachs, have upgraded Bayer's rating from "hold" to "strong-buy," indicating positive sentiment among analysts.
• The company reported earnings of $0.35 per share, exceeding analysts' expectations, and had revenue of $12.42 billion, significantly higher than the anticipated $10.79 billion.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report)'s share price gapped down before the market opened on Thursday . The stock had previously closed at $8.70, but opened at $8.50. Bayer Aktiengesellschaft shares last traded at $8.51, with a volume of 108,617 shares.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on BAYRY. Zacks Research raised Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Tuesday. Kepler Capital Markets raised Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report on Wednesday, June 11th. The Goldman Sachs Group raised Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Thursday, June 5th. Hsbc Global Res raised Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 11th. Finally, Wall Street Zen raised Bayer Aktiengesellschaft from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, August 19th. Three equities research analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. Based on data from MarketBeat, Bayer Aktiengesellschaft presently has a consensus rating of "Strong Buy".

Bayer Aktiengesellschaft Stock Down 2.6%

The stock has a market cap of $33.30 billion, a price-to-earnings ratio of -8.74, a PEG ratio of 3.78 and a beta of 0.90. The company has a quick ratio of 0.73, a current ratio of 1.13 and a debt-to-equity ratio of 1.04. The stock has a fifty day moving average of $8.06 and a two-hundred day moving average of $7.32.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.10. Bayer Aktiengesellschaft had a positive return on equity of 15.44% and a negative net margin of 7.61%.The firm had revenue of $12.42 billion for the quarter, compared to analysts' expectations of $10.79 billion. As a group, analysts predict that Bayer Aktiengesellschaft will post 1.31 EPS for the current fiscal year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.